Darko Skegro

Person

Grenchen, CH

People

Patents Grantslast 30 patents

Information Patent Grant
CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and meth...
- Patent number 12,006,367
- Issue date Jun 11, 2024
- Ichnos Sciences SA
- Romain Ollier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Production of T cell retargeting hetero-dimeric immunoglobulins
- Patent number 11,891,454
- Issue date Feb 6, 2024
- Ichnos Sciences SA
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Production of T cell retargeting hetero-dimeric immunoglobulins
- Patent number 11,851,502
- Issue date Dec 26, 2023
- Ichnos Sciences SA
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and meth...
- Patent number 11,773,166
- Issue date Oct 3, 2023
- Ichnos Sciences SA
- Romain Ollier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered heterodimeric proteins
- Patent number 11,685,776
- Issue date Jun 27, 2023
- Novartis AG
- Regis Cebe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fc variant antibodies and their uses
- Patent number 11,267,891
- Issue date Mar 8, 2022
- Sanofi
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hetero-dimeric immunoglobulins
- Patent number 9,683,053
- Issue date Jun 20, 2017
- Glenmark Pharmaceuticals S.A.
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hetero-dimeric immunoglobulins
- Patent number 9,683,052
- Issue date Jun 20, 2017
- Glenmark Pharmaceuticals S.A.
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Production of T cell retargeting hetero-dimeric immunoglobulins
- Patent number 9,493,563
- Issue date Nov 15, 2016
- Glenmark Pharmaceuticals S.A.
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies that bind to TL1A and their uses
- Patent number 9,290,576
- Issue date Mar 22, 2016
- GLENMARK PHARMACEUTICALS S.A.
- Antoine Attinger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-alpha2 integrin antibodies and their uses
- Patent number 8,975,376
- Issue date Mar 10, 2015
- Sanofi
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibodies that bind to CD19 and their uses
- Patent number 8,679,492
- Issue date Mar 25, 2014
- Glenmark Pharmaceuticals S.A.
- Stanislas Blein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ENGINEERED FC VARIANTS
- Publication number 20250011428
- Publication date Jan 9, 2025
- Novartis AG
- Justine Celine Patricia GUYOT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
- Publication number 20250000973
- Publication date Jan 2, 2025
- Novartis AG
- Michael Bardroff
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD19 BINDING MOLECULES AND USES THEREOF
- Publication number 20240025993
- Publication date Jan 25, 2024
- Regis CEBE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY Fc VARIANTS
- Publication number 20240002509
- Publication date Jan 4, 2024
- Novartis AG
- Brian Walter GRANDA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THERAPEUTIC FUSION PROTEINS
- Publication number 20230308835
- Publication date Sep 28, 2023
- Novartis AG
- Sebastien IRIGARAY
- H04 - ELECTRIC COMMUNICATION TECHNIQUE
Information Patent Application
COMPOSITIONS AND METHODS FOR IN VIVO GENERATION OF CAR EXPRESSING C...
- Publication number 20230302155
- Publication date Sep 28, 2023
- Novartis AG
- Sandeep Tharian Koshy
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED HETERODIMERIC PROTEINS
- Publication number 20230295291
- Publication date Sep 21, 2023
- Novartis AG
- Regis CEBE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED IMMUNOGLOBULINS
- Publication number 20230242647
- Publication date Aug 3, 2023
- Novartis AG
- John BLANKENSHIP
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC FUSION PROTEINS
- Publication number 20230220048
- Publication date Jul 13, 2023
- Novartis AG
- Sebastien IRIGARAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOGLOBULIN VARIANTS
- Publication number 20230167193
- Publication date Jun 1, 2023
- Novartis AG
- John BLANKENSHIP
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METH...
- Publication number 20230062624
- Publication date Mar 2, 2023
- Ichnos Sciences SA.
- Romain OLLIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODUCTION OF T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS
- Publication number 20210171661
- Publication date Jun 10, 2021
- Ichnos Sciences SA.
- Stanislas BLEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRISPECIFIC BINDING MOLECULES AGAINST TUMOR-ASSOCIATED ANTIGENTS AN...
- Publication number 20200362054
- Publication date Nov 19, 2020
- Brian GRANDA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES THAT BIND TO TL1A AND THEIR USES
- Publication number 20200079863
- Publication date Mar 12, 2020
- Glenmark Pharmaceuticals S.A.
- ANTOINE ATTINGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hetero-Dimeric Immunoglobulins
- Publication number 20200024367
- Publication date Jan 23, 2020
- Glenmark Pharmaceuticals S.A.
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED HETERODIMERIC PROTEINS
- Publication number 20190382475
- Publication date Dec 19, 2019
- Novartis AG
- Regis CEBE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METH...
- Publication number 20190135918
- Publication date May 9, 2019
- Glenmark Pharmaceuticals S.A.
- Romain OLLIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODUCTION OF T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS
- Publication number 20180355064
- Publication date Dec 13, 2018
- Glenmark Pharmaceuticals S.A.
- Stanislas BLEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hetero-Dimeric Immunoglobulins
- Publication number 20180094077
- Publication date Apr 5, 2018
- Glenmark Pharmaceuticals S.A.
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES THAT BIND TO TL1A AND THEIR USES
- Publication number 20180086840
- Publication date Mar 29, 2018
- Glenmark Pharmaceuticals S.A.
- ANTOINE ATTINGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVA...
- Publication number 20170218087
- Publication date Aug 3, 2017
- Glenmark Pharmaceuticals S.A.
- Stanislas BLEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Production of T cell retargeting hetero-dimeric immunoglobulins
- Publication number 20170145115
- Publication date May 25, 2017
- Glenmark Pharmaceuticals S.A.
- Stanislas BLEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIV...
- Publication number 20160319027
- Publication date Nov 3, 2016
- Glenmark Pharmaceuticals S.A.
- Stanislas BLEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES
- Publication number 20150232559
- Publication date Aug 20, 2015
- SANOFI
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVA...
- Publication number 20150183885
- Publication date Jul 2, 2015
- Glenmark Pharmaceuticals S.A.
- Stanislas BLEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Production of T cell retargeting hetero-dimeric immunoglobulins
- Publication number 20150133640
- Publication date May 14, 2015
- Stanislas BLEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES THAT BIND TO TL1A AND THEIR USES
- Publication number 20140308271
- Publication date Oct 16, 2014
- Glenmark Pharmaceuticals S.A.
- ANTOINE ATTINGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES THAT BIND TO CD19 AND THEIR USES
- Publication number 20140286934
- Publication date Sep 25, 2014
- Glenmark Pharmaceuticals S.A.
- STANISLAS BLEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hetero-Dimeric Immunoglobulins
- Publication number 20140187753
- Publication date Jul 3, 2014
- Glenmark Pharmaceuticals S.A.
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hetero-Dimeric Immunoglobulins
- Publication number 20140066599
- Publication date Mar 6, 2014
- Glenmark Pharmaceuticals S.A.
- Stanislas Blein
- C07 - ORGANIC CHEMISTRY

Darko Skegro

Person

Patents Grantslast 30 patents

CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and meth...

Production of T cell retargeting hetero-dimeric immunoglobulins

Production of T cell retargeting hetero-dimeric immunoglobulins

CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and meth...

Engineered heterodimeric proteins

Fc variant antibodies and their uses

Hetero-dimeric immunoglobulins

Hetero-dimeric immunoglobulins

Production of T cell retargeting hetero-dimeric immunoglobulins

Antibodies that bind to TL1A and their uses

Anti-alpha2 integrin antibodies and their uses

Humanized antibodies that bind to CD19 and their uses

Patents Applicationslast 30 patents

ENGINEERED FC VARIANTS

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

CD19 BINDING MOLECULES AND USES THEREOF

ANTIBODY Fc VARIANTS

THERAPEUTIC FUSION PROTEINS

COMPOSITIONS AND METHODS FOR IN VIVO GENERATION OF CAR EXPRESSING C...

ENGINEERED HETERODIMERIC PROTEINS

ENGINEERED IMMUNOGLOBULINS

THERAPEUTIC FUSION PROTEINS

IMMUNOGLOBULIN VARIANTS

CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METH...

PRODUCTION OF T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

TRISPECIFIC BINDING MOLECULES AGAINST TUMOR-ASSOCIATED ANTIGENTS AN...

ANTIBODIES THAT BIND TO TL1A AND THEIR USES

Hetero-Dimeric Immunoglobulins

ENGINEERED HETERODIMERIC PROTEINS

CD3/CD38 T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS AND METH...

PRODUCTION OF T CELL RETARGETING HETERO-DIMERIC IMMUNOGLOBULINS

Hetero-Dimeric Immunoglobulins

ANTIBODIES THAT BIND TO TL1A AND THEIR USES

ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVA...

Production of T cell retargeting hetero-dimeric immunoglobulins

ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIV...

ANTI-ALPHA2 INTEGRIN ANTIBODIES AND THEIR USES

ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVA...

Production of T cell retargeting hetero-dimeric immunoglobulins

ANTIBODIES THAT BIND TO TL1A AND THEIR USES

HUMANIZED ANTIBODIES THAT BIND TO CD19 AND THEIR USES

Hetero-Dimeric Immunoglobulins

Hetero-Dimeric Immunoglobulins